XML 30 R15.htm IDEA: XBRL DOCUMENT
v3.26.1

DERIVATIVES | 3 Months Ended
--- | ---
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
DERIVATIVES | DERIVATIVES Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):
| March 31, 2026 |  | December 31, 2025
Assets: |  |  |
Other invested assets: |  |  |
Fixed indexed call options | $ | 195.2 |  |  | $ | 323.5 |
Reinsurance receivables | (15.7) |  |  | (15.3) |
Total assets | $ | 179.5 |  |  | $ | 308.2 |
Liabilities: |  |  |
Embedded derivatives related to fixed indexed annuities at fair value: |  |  |
Policyholder account balances | $ | 1,564.2 |  |  | $ | 1,600.6 |
Our fixed indexed annuity products provide a guaranteed minimum rate of return on the fixed fund portion of the contracts and a higher potential return on the index portion of the contract that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. We are generally able to change the participation rate at the beginning of each index period (typically on each policy anniversary date), subject to contractual minimums. The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. We are required to record the embedded derivatives related to our fixed indexed annuity products at estimated fair value. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked. The notional amount of these options was $4.4 billion and $4.5 billion at March 31, 2026 and December 31, 2025, respectively. Purchases of fixed indexed call options that are used to hedge the effects of certain policyholder benefits were $52.0 million and $51.2 million during the three months ended March 31, 2026 and 2025, respectively. Sales, which generally represent option exercises, were $115.5 million and $110.0 million, respectively, during the three months ended March 31, 2026 and 2025. We are required to establish an embedded derivative related to a modified coinsurance agreement pursuant to which we assume the risks of a block of health insurance business. The embedded derivative represents the mark-to-market adjustment for $68.1 million in underlying investments held by the ceding reinsurer at March 31, 2026. We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in other investment gains (losses) on the consolidated statement of operations. The following table provides the pre-tax impact recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):
| Three months ended |  |
| March 31, |  |
| 2026 |  | 2025 |  |  |  |
Net investment income (loss) from policyholder and other special-purpose portfolios: |  |  |  |  |  |  |
Fixed indexed call options | $ | (64.8) |  |  | $ | (70.6) |  |  |  |  |
Total investment gains (losses): |  |  |  |  |  |  |
Embedded derivative related to modified coinsurance agreement | (0.4) |  |  | 1.2 |  |  |  |  |
Total revenues from derivative instruments, not designated as hedges | (65.2) |  |  | (69.4) |  |  |  |  |
Insurance policy benefits: |  |  |  |  |  |  |
Embedded derivatives related to fixed indexed annuities | (27.0) |  |  | (2.8) |  |  |  |  |
Net pre-tax impact | $ | (38.2) |  |  | $ | (66.6) |  |  |  |  |
Derivative Counterparty Risk If the counterparties to the call options fail to meet their obligations, we may recognize a loss. We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy. At March 31, 2026, all of our counterparties were rated "A" or higher by S&P Global Ratings ("S&P"). The Company and its subsidiaries are parties to master netting arrangements with its counterparties related to entering into various derivative contracts. The following table summarizes information related to derivatives with master netting arrangements or collateral as of March 31, 2026 and December 31, 2025 (dollars in millions):
|  |  |  |  |  |  |  |  | Gross amounts not offset in the balance sheet |  |
|  |  | Gross amounts recognized |  | Gross amounts offset in the balance sheet |  | Net amounts of assets presented in the balance sheet |  | Non-cash collateral |  | Cash collateral received |  | Net amount
March 31, 2026: |  |
| Fixed indexed call options |  | $ | 195.2 |  |  | $ | — |  |  | $ | 195.2 |  |  | $ | 19.4 |  |  | $ | — |  |  | $ | 175.8 |
December 31, 2025: |  |  |  |  |  |  |  |  |  |  |  |
| Fixed indexed call options |  | 323.5 |  |  | — |  |  | 323.5 |  |  | 43.5 |  |  | — |  |  | 280.0 |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivatives and fair value of assets and liabilities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent + Details
Name: | us-gaap_DerivativesAndFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration